Senate Panel Passes Breakthrough Device, Other Measures; FDA Funding Debated

10 Mar 2016

The Senate HELP Committee voted March 9 in favor of a breakthrough device provision, watered down from a version approved in the House last year. Other bills voted out of committee include a combination products reform measure, the digital-health focused MEDTECH Act, and four others. Senators are still debating whether NIH and FDA should get additional funds to cover the cost of the bills, which will be wrapped up into a broader package before Senate floor debate.

The Senate Health, Education, Labor and Pensions Committee passed breakthrough medical device legislation, as well as combination products and digital health regulatory reform bills, on March 9 as part of the panel's effort to pass a broad-reaching biomedical innovation package this year.

In all, the committee approved seven health care bills at the recent hearing, following seven that passed through the committee in February. (See [A#01160215009].)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

20 May 2025

• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

20 May 2025

• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.